-
公开(公告)号：US08671945B2
公开(公告)日：2014-03-18
申请号：US13225829
申请日：2011-09-06
IPC分类号： A61F6/06
CPC分类号： A61K9/7053 , A61K31/57 , A61K2300/00
摘要： The present invention relates to the field of pharmaceutical formulation techniques. The invention provides a low dosage pharmaceutical composition for transdermal delivery of hormones, preferably a progestin, such as a Gestodene, and an estrogen, preferably Ethinylestradiol so as to achieve plasma concentration profiles effective in inhibiting ovulation in a woman.
摘要翻译： 本发明涉及药物制剂技术领域。 本发明提供了一种低剂量药物组合物，其用于经皮递送激素，优选孕激素，例如Gestodene和雌激素，优选乙炔雌二醇，以达到有效抑制女性排卵的血浆浓度分布。
-
公开(公告)号：US08022053B2
公开(公告)日：2011-09-20
申请号：US11262952
申请日：2005-11-01
IPC分类号： A61K31/56
CPC分类号： A61K31/56 , A61K9/2009 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K9/2813 , A61K9/284 , A61K9/2866
摘要： The present invention relates to oral solid dosage forms containing a very low dose of estradiol. The dosage forms are formulated in a manner so as to avoid degradation of the estradiol and to minimise the content of polyvinylpyrrolidone, while still achieving similar fast dissolution of the estradiol. The dosage forms are useful in preventing or treating a physical condition in a woman caused by insufficient endogenous levels of estradiol.
摘要翻译： 本发明涉及含有非常低剂量的雌二醇的口服固体剂型。 剂型配制以避免雌二醇降解并使聚乙烯吡咯烷酮的含量最小化，同时仍然实现雌二醇的类似的快速溶解。 剂型可用于预防或治疗由内源性雌二醇不足引起的妇女的身体状况。
-
公开(公告)号：US20110097405A1
公开(公告)日：2011-04-28
申请号：US12867409
申请日：2009-02-05
申请人： Adrian Funke , Sascha General , Ildikó Terebesi , Christian Zurth , Sofia Alincic-kunz , Matthias Schäfer , Thomas Holler , Konstanze Diefenbach
发明人： Adrian Funke , Sascha General , Ildikó Terebesi , Christian Zurth , Sofia Alincic-kunz , Matthias Schäfer , Thomas Holler , Konstanze Diefenbach
CPC分类号： A61K9/006 , A61K31/565
摘要： The present invention relates to drug delivery systems in the form of thin water-soluble films (wafers), which contain estradiol, or derivatives thereof, in low amounts. The wafers of the present invention are suitable for treating, alleviating or preventing a physical condition in a female mammal caused by insufficient endogenous levels of estrogen.
摘要翻译： 本发明涉及以少量含有雌二醇或其衍生物的薄水溶性薄膜（晶片）形式的药物递送系统。 本发明的晶片适用于治疗，减轻或预防由雌激素内源水平不足导致的女性哺乳动物的身体状况。
-
公开(公告)号：US20060111334A1
公开(公告)日：2006-05-25
申请号：US11262952
申请日：2005-11-01
IPC分类号： A61K31/56
CPC分类号： A61K31/56 , A61K9/2009 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K9/2813 , A61K9/284 , A61K9/2866
摘要： The present invention relates to oral solid dosage forms containing a very low dose of estradiol. The dosage forms are formulated in a manner so as to avoid degradation of the estradiol and to minimise the content of polyvinylpyrrolidone, while still achieving similar fast dissolution of the estradiol. The dosage forms are useful in preventing or treating a physical condition in a woman caused by insufficient endogenous levels of estradiol.
摘要翻译： 本发明涉及含有非常低剂量的雌二醇的口服固体剂型。 剂型配制以避免雌二醇降解并使聚乙烯吡咯烷酮的含量最小化，同时仍然实现雌二醇的类似的快速溶解。 剂型可用于预防或治疗由内源性雌二醇不足引起的妇女的身体状况。
-
公开(公告)号：US5746999A
公开(公告)日：1998-05-05
申请号：US484309
申请日：1995-06-07
CPC分类号： C08B37/0021 , G01N2400/14 , G01N2400/22 , G01N2446/20 , G01N2446/30 , G01N2446/86
摘要： Agents containing magnetic particles are suitable for use in enhancing images in diagnostic procedures, e.g., via x-ray, ultrasound or especially NMR. Preferred particles are based on metals, e.g., iron, cobalt or nickel, double metal oxides/hydroxides or complexes thereof.
-
-
-
-
搜索结果
5 条记录 (耗时 0.017 秒)
